Effect of dexmedetomidine on heart rate-corrected QT and Tpeak-Tend intervals during robot-assisted laparoscopic prostatectomy with steep trendelenburg position: A prospective, randomized, double-blinded, controlled study

Na Young Kim, Dong Woo Han, Jae Chul Koh, Koon Ho Rha, Jung Hwa Hong, Jong Min Park, So Yeon Kim

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

Intraperitoneal insufflation of carbon dioxide may affect the sympathetic activity that leads to changes in ventricular repolarization. This in turn can result in changes of heart rate-corrected QT (QTc) interval and Tpeak-Tend (Tp-e) interval. Dexmedetomidine is a highly selective a2-receptor agonist and has potential antiarrhythmic properties. This prospective, randomized, double-blinded, controlled study evaluated the effects of dexmedetomidine administration on QTc and Tp-e intervals during robot-assisted laparoscopic prostatectomy with steep Trendelenburg position. Fifty patients scheduled for robot-assisted laparoscopic prostatectomy randomly received either a continuous infusion of dexmedetomidine at a rate of 0.3mg/kg/hour, from anesthetic induction until the end of the Trendelenburg position (dexmedetomidine group; n=25), or the same volume of normal saline (control group; n=25). Anesthesia was maintained with sevoflurane and remifentanil. The primary and secondary goalswere to evaluate the effect of dexmedetomidine on theQTc and Tp-e interval changes. Mean arterial pressure, heart rate, end-tidal CO2, and end-tidal sevoflurane concentrations were assessed as well. Forty-seven patients (94%) completed the study. Dexmedetomidine significantly attenuated QTc interval prolongation and reduced the Tp-e interval, even though the baseline values of the QTc and Tp-e intervals were similar between the 2 groups (PGroup ± Time=0.001 and 0.014, respectively). Twenty-two patients (96%) in the control group and 13 (54%) in the dexmedetomidine group had QTc interval prolongation of >20ms from the baseline value during surgery (P=0.001). The maximum QTc interval prolongation from the baseline value during surgery was 46±21ms in the control group and 24±21ms in the dexmedetomidine group (mean±SD, P=0.001). Mean arterial pressure and heart rate were comparable between the groups. Continuous infusion of dexmedetomidine at a rate of 0.3mg/kg/hour significantly attenuated the QTc interval prolongation induced by CO2 pneumoperitoneum with steep Trendelenburg position. Furthermore, dexmedetomidine reduced the Tp-e interval. Thus, dexmedetomidine administration may be effective for patients who are susceptible to the development of ventricular arrhythmia during robot-assisted laparoscopic prostatectomy.

Original languageEnglish
Article numbere3645
JournalMedicine (United States)
Volume95
Issue number19
DOIs
Publication statusPublished - 2016

Bibliographical note

Publisher Copyright:
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Effect of dexmedetomidine on heart rate-corrected QT and Tpeak-Tend intervals during robot-assisted laparoscopic prostatectomy with steep trendelenburg position: A prospective, randomized, double-blinded, controlled study'. Together they form a unique fingerprint.

Cite this